Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
02/26/2009 | WO2009026359A2 Improved devices for cell assays |
02/26/2009 | WO2009026278A1 Methods and compositions for assaying regulatory t cells |
02/26/2009 | WO2009026252A1 Methods for assaying alpha-l-iduronidase enzymatic activity |
02/26/2009 | WO2009026168A1 Anti-antibody reagent |
02/26/2009 | WO2009026152A1 Metabolomic profiling of prostate cancer |
02/26/2009 | WO2009026074A1 Simultaneous assay for determining drugs |
02/26/2009 | WO2009025854A1 Smips: small molecule inhibitors of p27 depletion in cancers and other proliferative diseases |
02/26/2009 | WO2009025767A1 Boron dipyrromethene difluoro (bodipy) conjugates |
02/26/2009 | WO2009025616A1 Read-out method and apparatus |
02/26/2009 | WO2009025488A2 Apparatus and method of analyzing constituents of gas in oral cavity and alveolar gas |
02/26/2009 | WO2009025475A2 The methods for detecting molecular interactions |
02/26/2009 | WO2009025401A1 Nesfatin-1 specific antibody and the use thereof, and nesfatin specific antibody and the use thereof |
02/26/2009 | WO2009025396A1 Method for detection or measurement of abnormal prion protein involved in transmissible spongiform encephalopathy |
02/26/2009 | WO2009025364A1 Non-specific reaction inhibitor |
02/26/2009 | WO2009025300A1 Peptide capable of binding to immunoglobulin |
02/26/2009 | WO2009025296A1 Method of detecting methylated cytosine |
02/26/2009 | WO2009025290A1 Method for quantification of titer of neurotoxin-neutralizing antibody |
02/26/2009 | WO2009025159A1 Detection and treatment of schizophrenia |
02/26/2009 | WO2009025149A1 Adnf receptor |
02/26/2009 | WO2009025094A1 Method of diagnosing cancer in mammal |
02/26/2009 | WO2009025080A1 Colorectal cancer marker polypeptide, and method for diagnosis of colorectal cancer |
02/26/2009 | WO2009024986A2 Regulatory sequences derived from il-10 promoter and uses thereof in modulation of immune response |
02/26/2009 | WO2009024956A1 A cuvette assembly, and a method for producing a cuvette assembly |
02/26/2009 | WO2009024922A2 Method of directing magnetic or magnetisable objects to prepare bio-sensor device |
02/26/2009 | WO2009024822A2 Diagnostic method and kit |
02/26/2009 | WO2009024805A1 An enzyme detection device |
02/26/2009 | WO2009024791A1 Detection and functionalisation of s-nitrosylated polypeptides |
02/26/2009 | WO2009024775A1 Bilayers |
02/26/2009 | WO2009024763A2 Combination therapy |
02/26/2009 | WO2009024726A2 Method for purifying or detecting a target protein |
02/26/2009 | WO2009024691A2 Method of assaying leukocyte elastase inhibitor for the in vitro diagnosis of colorectal cancer |
02/26/2009 | WO2009024653A1 Anti-idiotypic antibodies which neutralise the inhibitory activity of an inhibitory antibody directed against the c1 domain of factor viii |
02/26/2009 | WO2009024646A1 Method and device for taking a sample |
02/26/2009 | WO2009024620A2 A process for isolation and purification of a target protein free of prion protein (prpsc) |
02/26/2009 | WO2009024526A1 Gas sensor |
02/26/2009 | WO2009024422A1 Method for producing purified and/or concentrated analytes, use and kit |
02/26/2009 | WO2009024413A1 Method of determining a concentration of analytes of interest in a sample |
02/26/2009 | WO2009024296A1 Use of ap-2 epsilon |
02/26/2009 | WO2009024239A2 Permissive cells and uses thereof |
02/26/2009 | WO2009024160A1 Prediction of non-fatal and fatal atherothrombotic events |
02/26/2009 | WO2009023995A1 Crystal structure of cd147 extracellular region and use thereof |
02/26/2009 | WO2009023955A1 Cytotoxicity mediation of cells evidencing surface expression of cd9 |
02/26/2009 | WO2009023953A1 Method for determining a value of a property of oil extracted from a sample |
02/26/2009 | WO2009003706A3 Methods, kits, and compounds for determining responsiveness to treatment of a pathological disorder by epothilones |
02/26/2009 | WO2009003493A3 Mhc multimers, methods for their generation, labeling and use |
02/26/2009 | WO2009002225A3 Multifunctional diagnosis device and a method for testing biological objects |
02/26/2009 | WO2009001017A3 Marking reagents bearing diazo and nitro functions, methods for the synthesis of such reagents and methods for detecting biological molecules |
02/26/2009 | WO2008157459A3 Methods and systems for identifying molecular pathway elements |
02/26/2009 | WO2008157311A3 5-bromo-2'-deoxy-uridine labeled nucleotide triphosphates and nucleic acid probes and methods of making and using the same |
02/26/2009 | WO2008156858A3 Use of pre-mrna splicing in platelet cells for the diagnosis of disease |
02/26/2009 | WO2008156617A3 Methods and kits for predicting treatment response in type ii diabetes mellitus patients |
02/26/2009 | WO2008155128A3 Method and device for positioning and optionally aligning an object |
02/26/2009 | WO2008154352A3 Genetic markers associated with endometriosis and use thereof |
02/26/2009 | WO2008154225A3 Microdeposition system for a biosensor |
02/26/2009 | WO2008153692A3 Microrna expression profiling of cerebrospinal fluid |
02/26/2009 | WO2008151146A3 Peptide arrays and methods of use |
02/26/2009 | WO2008150091A3 Novel analytical method for protein |
02/26/2009 | WO2008141285A9 Methods for early diagnosis of kidney disease |
02/26/2009 | WO2008141243A3 Device and methods for calibrating analyte sensors |
02/26/2009 | WO2008140580A3 Specific antibody selection by selective elution conditions |
02/26/2009 | WO2008138547A3 Improved infant formula containing an aroma composition for use as fragrance |
02/26/2009 | WO2008137834A3 Crystal structure of smyd3 protein |
02/26/2009 | WO2008132447A3 Calibrator for a gas analyser |
02/26/2009 | WO2008119527A3 Agonists of bitter taste receptors and uses thereof |
02/26/2009 | WO2008117024A3 System and method for spot check analysis or spot sampling of a multiphase mixture flowing in a pipeline |
02/26/2009 | WO2008115714A3 Evaluating rtk target drugs |
02/26/2009 | WO2008114152A3 A novel diagnostic sensor for rapid and reproducible ro52 protein domain detection |
02/26/2009 | WO2008100288A3 High affinity ephb receptor binding compounds and methods of use thereof |
02/26/2009 | WO2008073148A3 Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
02/26/2009 | WO2008014916A9 Screening method for the isolation of centrosomal cluster-inhibitors as anti-cancer agents |
02/26/2009 | WO2007146401A3 Denatured collagen peptides and uses thereof |
02/26/2009 | WO2007120805A3 System and apparatus for automated protein analysis |
02/26/2009 | WO2007041394A3 Reactive surfaces, substrates and methods for producing and using same |
02/26/2009 | WO2006086150A3 Phuman t2r receptors for acetaminophen, ranitidine, strychnine and denatonium and related assays for identifying human bitter taste modulators |
02/26/2009 | WO2006084050A9 Libraries and methods for isolating antibodies |
02/26/2009 | US20090055939 Probe for detection and quantification of nitric oxide, and method for detecting and quantifying nitric oxide using the same |
02/26/2009 | US20090055101 Method for estimating molecule concentrations in a sampling and equipment therefor |
02/26/2009 | US20090055100 Method for identifying and/or characterizing a (poly)peptide |
02/26/2009 | US20090055099 Proteomic analysis of biological fluids |
02/26/2009 | US20090054810 Analyte concentration detection devices and methods |
02/26/2009 | US20090054753 Variable Sampling Interval for Blood Analyte Determinations |
02/26/2009 | US20090054633 Method for Controlling Stability of Nanofabricated Polypeptide Multilayer Films, Coatings, and Microcapsules |
02/26/2009 | US20090054630 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
02/26/2009 | US20090054624 useful in the treatment of a condition which is responsive to the PRO polypeptide, an agonist or antagonist thereof or an anti-PRO antibody |
02/26/2009 | US20090054510 Method for identifying compounds for the treatment of depression |
02/26/2009 | US20090054367 Mycobacterial antigens expressed under low oxygen tension |
02/26/2009 | US20090054321 Polypeptides and use thereof |
02/26/2009 | US20090054312 SMIPs: Small molecule inhibitors of p27 depletion in cancers and other proliferative diseases |
02/26/2009 | US20090054300 Using protein profiles aspredictive tools in prognosis and treatment of immune related disorders |
02/26/2009 | US20090054267 Active nems arrays for biochemical analyses |
02/26/2009 | US20090054265 Chemical Screening System Using Strip Arrays |
02/26/2009 | US20090054263 Grating waveguide structure for multi-analyte determinations and the use thereof |
02/26/2009 | US20090054262 Devices for cell assays |
02/26/2009 | US20090054259 Methods for inducing complete apoptosis of liver cells expressing hbchi protein and screening for substances or genes that inhibit the apoptosis |
02/26/2009 | US20090054257 Method of improving t cell receptors |
02/26/2009 | US20090054252 Hemopexin-Like Structure as New Polypeptide-Scaffold |
02/26/2009 | US20090054251 Diagnosis of Autoimmune Disease |
02/26/2009 | US20090054248 Connexin 40 tissue specific gene mutations |
02/26/2009 | US20090053989 Interior Air Quality Space and Methods of Designing and Constructing Same |
02/26/2009 | US20090053832 Simultaneous assay for determining drugs |